BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36257308)

  • 1. [Functional characterization of patients with isolated post-capillary or combined post-capillary and pre-capillary pulmonary hypertension].
    Held M; Weiner S; Walthelm J; Joa F; Hoffmann J; Güder G; Pfeuffer-Jovic E
    Pneumologie; 2022 Oct; 76(10):689-696. PubMed ID: 36257308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional characterization of patients with isolated post-capillary or combined post-capillary and pre-capillary pulmonary hypertension].
    Held M; Weiner S; Walthelm J; Joa F; Hoffmann J; Güder G; Pfeuffer-Jovic E
    Dtsch Med Wochenschr; 2021 Oct; 146(21):e88-e94. PubMed ID: 34670324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Combined Pre and Postcapillary Pulmonary Hypertension on Survival after Transcatheter Aortic Valve Implantation.
    Sultan I; Fukui M; Bianco V; Brown JA; Kliner DE; Hickey G; Thoma FW; Lee JS; Schindler JT; Kilic A; Gleason TG; Cavalcante JL
    Am J Cardiol; 2020 Sep; 131():60-66. PubMed ID: 32713655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease.
    Gong C; Guo X; Wan K; Chen C; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen Y
    J Magn Reson Imaging; 2023 May; 57(5):1518-1528. PubMed ID: 37021578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component.
    Caravita S; Faini A; Deboeck G; Bondue A; Naeije R; Parati G; Vachiéry JL
    J Heart Lung Transplant; 2017 Jul; 36(7):754-762. PubMed ID: 28131663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic mechanisms and long-term prognostic impact of pulmonary hypertension in patients with severe aortic stenosis undergoing valve replacement.
    Weber L; Rickli H; Haager PK; Joerg L; Weilenmann D; Brenner R; Taramasso M; Baier P; Maisano F; Maeder MT
    Eur J Heart Fail; 2019 Feb; 21(2):172-181. PubMed ID: 30328215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement.
    Maeder MT; Weber L; Weilenmann D; Chronis J; Joerg L; Pohle S; Haager PK; Brutsche M; Neumann T; Schoch OD; Rickli H
    Clin Cardiol; 2021 Sep; 44(9):1276-1285. PubMed ID: 34219245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diagnostic Challenge of Group 2 Pulmonary Hypertension.
    Naeije R; D'Alto M
    Prog Cardiovasc Dis; 2016; 59(1):22-9. PubMed ID: 27195751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the 2022 pulmonary hypertension definition on haemodynamic classification and mortality in patients with aortic stenosis undergoing valve replacement.
    Maeder MT; Weber L; Pohle S; Chronis J; Baty F; Rigger J; Brutsche M; Haager P; Rickli H; Brenner R
    Eur Heart J Open; 2024 May; 4(3):oeae037. PubMed ID: 38812478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
    Omote K; Sorimachi H; Obokata M; Reddy YNV; Verbrugge FH; Omar M; DuBrock HM; Redfield MM; Borlaug BA
    Eur Heart J; 2022 Sep; 43(36):3417-3431. PubMed ID: 35796488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the new definition of pulmonary hypertension according to world symposium of pulmonary hypertension 2018 on diagnosis of post-capillary pulmonary hypertension.
    Pfeuffer-Jovic E; Weiner S; Wilkens H; Schmitt D; Frantz S; Held M
    Int J Cardiol; 2021 Jul; 335():105-110. PubMed ID: 33823213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension.
    Hungerford SL; Kearney K; Song N; Bart N; Kotlyar E; Lau E; Jabbour A; Hayward CS; Muller DWM; Adji A
    ESC Heart Fail; 2023 Jun; 10(3):1811-1821. PubMed ID: 36896830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary hypertension associated with left heart disease (group 2)].
    Schmidt KH; Bikou O; Blindt R; Bruch L; Felgendreher R; Hohenforst-Schmidt W; Holt S; Ladage D; Pfeuffer-Jovic E; Rieth A; Schmeisser A; Schnitzler K; Stadler S; Steringer-Mascherbauer R; Yogeswaran A; Kuebler WM
    Pneumologie; 2023 Nov; 77(11):926-936. PubMed ID: 37963482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Acute Vasodilator Testing Using Oxygen in Pulmonary Hypertension Due to Left Heart Disease.
    Rajkumar S; Jha AK; Parida S; Thangaswamy CR; Panneerselvam S; Prasad SKS
    Semin Cardiothorac Vasc Anesth; 2024 Mar; 28(1):8-17. PubMed ID: 38197387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics and Extreme Phenotyping Reveal Longitudinal Association Between Left Atrial Size and Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension.
    Kelly NJ; Newhouse D; Chapagain H; Patel A; Tang Y; Howard A; Kirillova A; Kim HJ; Rahman H; El Khoury W; Nouraie SM; Hickey G; Sade LE; Jain S; Chan SY
    J Am Heart Assoc; 2023 Dec; 12(23):e031746. PubMed ID: 38014658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension.
    Kramer T; Dumitrescu D; Gerhardt F; Orlova K; Ten Freyhaus H; Hellmich M; Baldus S; Rosenkranz S
    Int J Cardiol; 2019 May; 283():152-158. PubMed ID: 30777406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thirty-year trends and outcome of isolated versus combined group 2 pulmonary hypertension after cardiac transplantation.
    Nasri A; Dupuis J; Carrier M; Racine N; Parent MC; Ducharme A; Fortier A; Hausermann L; White M; Tremblay-Gravel M
    Front Cardiovasc Med; 2022; 9():841025. PubMed ID: 36531737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization.
    Correale M; Monaco I; Ferraretti A; Tricarico L; Sicuranza M; Gallotta AM; Formica ES; Acanfora G; Di Biase M; Brunetti ND
    Int J Cardiol Heart Vasc; 2020 Jun; 28():100513. PubMed ID: 32346602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Diastolic Dysfunction and Pulmonary Hypertension: Outcomes in SAVR.
    Liu TX; Tanenbaum MT; Seo CH; Park D; Lystash JC; Joseph M; Arnold WS
    Thorac Cardiovasc Surg; 2023 Aug; 71(5):398-406. PubMed ID: 33862634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.